I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Targeting KRAS Mutant Cancers via Combination Treatment: Di..:
Malcolm P. Huestis (10493092)
;
Darlene Dela Cruz (10493095)
;
Antonio G. DiPasquale (1274730)
...
https://figshare.com/articles/dataset/Targeting_KRAS_Mutant_Cancers_via_Combination_Treatment_Discovery_of_a_5_Fluoro-4-_3_i_H_i_quinazolinone_Aryl_Urea_pan-RAF_Kinase_Inhibitor/14336950. , 2021
Link:
https://doi.org/10.1021/acs.jmedchem.0c02085.s003
RT Journal T1
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5‑Fluoro-4-(3 H )‑quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14336950&Exemplar=1&LAN=DE A1 Malcolm P. Huestis (10493092) A1 Darlene Dela Cruz (10493095) A1 Antonio G. DiPasquale (1274730) A1 Matthew R. Durk (7052600) A1 Charles Eigenbrot (1346406) A1 Paul Gibbons (114343) A1 Alberto Gobbi (1508113) A1 Thomas L. Hunsaker (3160575) A1 Hank La (438084) A1 Dennis H. Leung (2106256) A1 Wendy Liu (2057074) A1 Shiva Malek (1346394) A1 Mark Merchant (282025) A1 John G. Moffat (413533) A1 Christine S. Muli (10493098) A1 Christine J. Orr (10493101) A1 Brendan T. Parr (2342548) A1 Frances Shanahan (655624) A1 Christopher J. Sneeringer (10493104) A1 Weiru Wang (640332) A1 Ivana Yen (1346373) A1 Jianping Yin (557395) A1 Michael Siu (1503160) A1 Joachim Rudolph (1464982) YR 2021 K1 Biophysics K1 Biochemistry K1 Medicine K1 Cell Biology K1 Molecular Biology K1 Pharmacology K1 Cancer K1 Hematology K1 Infectious Diseases K1 Virology K1 Space Science K1 Chemical Sciences not elsewhere classified K1 Physical Sciences not elsewhere classified K1 kinase selectivity K1 vivo evaluation K1 solubility K1 Combination Treatment K1 MEK inhibitor cobimetinib K1 tumor growth inhibition K1 NH functionality K1 pathway inhibition K1 Strategic substitution K1 fluoroquinazolinone hinge-binding motif K1 xenograft mouse model K1 C 5 position K1 RAF-specific residue interactions K1 aryl urea RAF inhibitors K1 type II pan-RAF inhibitor GNE -0749 K1 Targeting KRAS Mutant Cancers JF https://figshare.com/articles/dataset/Targeting_KRAS_Mutant_Cancers_via_Combination_Treatment_Discovery_of_a_5_Fluoro-4-_3_i_H_i_quinazolinone_Aryl_Urea_pan-RAF_Kinase_Inhibitor/14336950 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.0c02085.s003 DO https://doi.org/10.1021/acs.jmedchem.0c02085.s003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)